Personalised emails written for every contact · 97% deliverability · live in 60 seconds
| Company | What they do | Location | Size | Hiring |
|---|---|---|---|---|
Initial Therapeuticsinitialtx.com |
Initial Therapeutics is a biotechnology company discovering and developing a new class of small-molecule medicines designed to hal | South San Francisco, California | 11-50 | — |
argenxargenx.com HDPUAV |
argenx is a global immunology company that engineers antibody-based medicines for severe autoimmune diseases by partnering with ac | Boston, Massachusetts | 1001-5000 | — |
Acellxacellx.com |
— | — | — | |
Anavex Life Sciencesanavex.com |
Anavex Life Sciences Corp. (Nasdaq: AVXL) is a publicly traded biopharmaceutical company developing novel therapeutics for neurode | New York City, New York | 11-50 | — |
Acumenpharmaacumenpharma.com |
— | — | — | |
Annovisbioannovisbio.com |
Annovis Bio (NYSE: ANVS) is a Phase 3 clinical-stage biotechnology company developing oral therapies for neurodegenerative disease | Malvern, Pennsylvania | 11-50 | — |
Biogenbiogen.com  HY DF SR |
Biogen is a biotechnology company founded in 1978 and headquartered in Cambridge, Massachusetts, that develops first-in-class medi | Cambridge, Massachusetts | 5000+ | — |
Denali Softwaredenali.com |
Denali Software is a provider of electronic design automation (EDA) tools and intellectual property (IP) for system-on-chip (SoC) | Sunnyvale, California | 11-50 | — |
Eikonokineeikonokine.com |
— | — | — | |
Lyellimmunopharmalyellimmunopharma.com |
— | — | — | |
Neurocrine Biosciencesneurocrine.com  MH JOOM |
Neurocrine Biosciences is a biopharmaceutical company founded in 1992 that discovers, develops, and commercializes FDA-approved tr | San Diego, California | 1001-5000 | — |
Orphazymeorphazyme.com |
Orphazyme is a biotechnology company developing innovative new therapies for a family of serious genetic disorders called lysosoma | Auburndale, Massachusetts | 51-200 | — |
Alexionalexion.com SUNFAG |
Alexion, AstraZeneca Rare Disease is a rare disease company headquartered in Boston that pioneered complement-system medicines ove | Boston, Massachusetts | 5000+ | — |
UCBucb.com AHFYCL |
UCB is a biopharmaceutical company developing and commercializing medicines in immunology and neurology, with five core products i | — | — | — |
Novartisnovartis.com  MLMS XZ |
Novartis is an innovative medicines company that discovers and commercializes medicines across cardiovascular, renal and metabolic | — | — | — |
AbbVieabbvie.com |
AbbVie is a global biopharmaceutical company that discovers and delivers innovative medicines and solutions for complex health iss | North Chicago, Illinois | 5000+ | — |
Rocheroche.com |
— | — | — | |
| Run live for more | ||||
Initial Therapeutics is a biotechnology company discovering and developing a new class of small-molecule medicines designed to halt pathogenic protein formation in the earliest stages, differentiated from protein degradation and other interventions that target proteins only after they have formed.
Companies like Initial Therapeutics include argenx, Acellx, Anavex Life Sciences, Acumenpharma, Annovisbio. See the full list of 24 competitors and alternatives above.
Initial Therapeutics has approximately 11-50 employees and is in the Biotechnology Research industry.
Initial Therapeutics is headquartered in South San Francisco, California.
Initial Therapeutics operates in the Biotechnology Research industry.
Key decision-makers and buying contacts at Initial Therapeutics are listed above, including leaders across executive, finance, sales and operations.